Phosphodiesterase-5 inhibitors as novel cardioprotective agents – have we reached threshold for large-scale clinical trials?

David Hutchings, Simon Anderson, Andrew Trafford

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Phosphodiesterase-5 inhibitors as novel cardioprotective agents – have we reached threshold for large-scale clinical trials?'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science